Further analysis of serum based EPCA-2 as a specific prostate cancer associated biomarker

被引：0
|
作者：
Leman, Eddy S.
Cannon, Grant W.
Trock, Bruce J.
Sokoll, Lori J.
Chan, Daniel W.
Mangold, Leslie A.
Partin, Alan W.
Nickel, J. Curtis
Dimitrakov, Jordan D.
Getzenberg, Robert H.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31632-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [21] Is serum calcium a biomarker of fatal prostate cancer?
    Schwartz, Gary G.
    FUTURE ONCOLOGY, 2009, 5 (05) : 577 - 580
  • [22] Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy
    Zhao, Zhigang
    Ma, Wenjing
    Zeng, Guohua
    Qi, Defeng
    Ou, Lili
    Liang, Yeping
    PROSTATE, 2012, 72 (03): : 270 - 279
  • [23] The occurrence of prostate-specific antigen - IgM immune complexes (IC) as novel serum biomarker for prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 163 - 163
  • [24] Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients
    Pietrzak, Sandra
    Marciniak, Wojciech
    Derkacz, Roza
    Matuszczak, Milena
    Kiljanczyk, Adam
    Baszuk, Piotr
    Bryskiewicz, Marta
    Sikorski, Andrzej
    Gronwald, Jacek
    Slojewski, Marcin
    Cybulski, Cezary
    Golab, Adam
    Huzarski, Tomasz
    Debniak, Tadeusz
    Lener, Marcin R.
    Jakubowska, Anna
    Kluz, Tomasz
    Soroka, Marianna
    Scott, Rodney J.
    Lubinski, Jan
    CANCERS, 2024, 16 (15)
  • [25] Prostate specific antigen as a biomarker for breast cancer: a meta-analysis study
    Li, H. -F.
    Xie, Q.
    Nie, Q-W.
    Ye, X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (13) : 4188 - 4195
  • [26] Serum Early Prostate Cancer Antigen (EPCA) as a Significant Predictor of Incidental Prostate Cancer in Patients Undergoing Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
    Zhao, Zhigang
    Zeng, Guohua
    Zhong, Wen
    PROSTATE, 2010, 70 (16): : 1788 - 1798
  • [27] Serum prostate-specific antigen screening for prostate cancer: Analysis of the costs and benefits
    Mermershtain, W.
    Bone, D.
    Shteiman, T.
    Ariad, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Serum procalcitonin levels in prostate cancer: A new biomarker?
    Canat, Luetfi
    Atalay, Hasan A.
    Can, Osman
    Alkan, Ilter
    OEtuenctemur, Alper
    UROLOGIA JOURNAL, 2018, 85 (02) : 46 - 50
  • [29] Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker
    Thompson, Ian M.
    Tangen, Catherine M.
    Kristal, Alan R.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (21)
  • [30] Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes
    Burgess, Earle F.
    Ham, Amy-Joan L.
    Tabb, David L.
    Billheimer, Dean
    Roth, Bruce J.
    Chang, Sam S.
    Cookson, Michael S.
    Hinton, Timothy J.
    Cheek, Kristin L.
    Hill, Salisha
    Pietenpol, Jennifer A.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (09) : 1223 - 1233
12345